Our Pricing

NAD+ Injections: Clinical Evidence and UK Safety Guidance

NAD+ injections have gained attention as a potential intervention for cellular energy metabolism and age-related decline. At Cured Pharmacy, our UK-registered clinical team frequently receives enquiries about nicotinamide adenine dinucleotide therapy, so we've compiled the current evidence, safety data, and regulatory position to help you make an informed decision.

What Are NAD+ Injections and How Do They Work?

Nicotinamide adenine dinucleotide (NAD+) is a coenzyme present in every cell of the human body, essential for energy production and DNA repair [1]. As we age, cellular NAD+ levels naturally decline, which some researchers believe may contribute to metabolic dysfunction and age-related conditions. NAD+ injections aim to restore these levels through direct intramuscular or intravenous administration, bypassing the digestive system.

Proponents of nad+ injections suggest they may support mitochondrial function, enhance cellular repair mechanisms, and improve energy metabolism [1]. The theoretical basis centres on NAD+'s role in activating sirtuins—proteins involved in cellular stress resistance and longevity pathways. However, it's crucial to distinguish between laboratory findings and clinically proven human benefits.

Unlike oral NAD+ supplements, which face significant bioavailability challenges due to degradation in the digestive tract, injectable formulations deliver the coenzyme directly into circulation [2]. This difference in delivery method is often cited as a key advantage, though robust comparative clinical trials in humans remain limited.

Clinical Evidence for NAD+ Injections: What the Research Shows

The current evidence base for nad+ injections in humans is modest compared to established medical interventions. A 2022 systematic review published in Nutrients found that whilst preclinical studies show promise for NAD+ precursors in metabolic health, high-quality randomised controlled trials specifically examining injectable NAD+ remain scarce [3].

Most published human studies have focused on oral NAD+ precursors like nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) rather than direct NAD+ administration [3][4]. These trials have demonstrated modest increases in circulating NAD+ levels, but clinical endpoints such as improved energy, cognitive function, or longevity have not been consistently proven across populations.

A small pilot study published in 2021 examined intravenous NAD+ in healthy adults and reported subjective improvements in energy and mental clarity, though the study lacked a placebo control group and included only 12 participants [4]. Larger, placebo-controlled trials are needed before definitive claims about efficacy can be made.

Gaps in Current Research

The majority of compelling NAD+ data comes from animal models and cell culture studies, which do not always translate to human physiology [1]. Whilst these findings are scientifically interesting, UK healthcare professionals require robust clinical trial evidence before recommending interventions to patients. At present, nad+ injections remain an area of active investigation rather than established medical practice.

Safety Profile and Potential Side Effects of NAD+ Injections

Injectable NAD+ therapy has been associated with several side effects in clinical observations, though serious adverse events appear uncommon in published literature [4]. Reported side effects include injection site reactions, flushing, nausea, headache, and muscle discomfort—particularly when administered rapidly via intravenous infusion.

The UK Medicines and Healthcare products Regulatory Agency (MHRA) does not currently license NAD+ as a prescription medicine for specific therapeutic indications. This means nad+ injections fall into a regulatory grey area, often provided through private clinics as an unlicensed treatment. Patients should be aware that unlicensed medicines have not undergone the same rigorous safety and efficacy review as MHRA-approved medications.

Long-term safety data for repeated NAD+ administration in humans is limited. Whilst short-term use appears generally well-tolerated in healthy adults, potential interactions with medications, effects in people with chronic conditions, and optimal dosing regimens have not been thoroughly established [2][4].

Who Should Avoid NAD+ Injections?

Pregnant or breastfeeding women should avoid nad+ injections due to lack of safety data in these populations. Individuals with cardiovascular conditions, liver disease, or kidney impairment should consult a healthcare professional before considering NAD+ therapy, as the metabolic effects and clearance pathways have not been fully characterised in these groups.

UK Regulatory Status and NAD+ Injections Guidance

In the United Kingdom, NAD+ is not classified as a controlled substance, but its use as an injectable medicine is subject to regulatory oversight. The MHRA has not granted marketing authorisation for NAD+ injections for any specific medical condition, meaning they cannot be legally prescribed through standard NHS or private prescription pathways for licensed indications.

Some private clinics offer nad+ injections as an unlicensed treatment under the principle of 'named patient' supply or as part of aesthetic medicine services. The General Pharmaceutical Council (GPhC) requires that any unlicensed medicine supplied by a UK pharmacy must meet strict quality standards and be prescribed by an appropriate healthcare professional following individual patient assessment.

At Cured Pharmacy, superintendent pharmacist Tarun Kumar (GPhC 2233073) emphasises that whilst we support evidence-based supplementation, patients should prioritise licensed, clinically proven interventions where available. Our team can provide guidance on licensed alternatives that support cellular health and energy metabolism through established pathways.

NAD+ Injections vs Oral NAD+ Precursors: Comparing Your Options

For patients interested in supporting NAD+ levels, oral precursors like nicotinamide riboside and nicotinamide mononucleotide represent more accessible and better-studied alternatives to injections [3]. These compounds are converted to NAD+ within cells and have demonstrated the ability to raise circulating NAD+ levels in clinical trials, albeit modestly.

Oral supplementation avoids the risks associated with injectable administration—such as infection, injection site reactions, and the need for clinical supervision. However, bioavailability remains a consideration, as not all orally consumed NAD+ precursors are efficiently absorbed and converted [2][3].

Comprehensive multivitamin formulations, such as Forceval Multivitamins & Minerals Capsules available from £46.59, provide the B-vitamin cofactors (including niacin, the precursor to NAD+) necessary for endogenous NAD+ synthesis. For many patients, optimising foundational nutrition through licensed, evidence-based supplements represents a more prudent first step than experimental injectable therapies.

Supporting Cellular Health Through Evidence-Based Nutrition

Maintaining adequate levels of B vitamins, particularly vitamin B3 (niacin), supports the body's natural NAD+ production pathways [1]. Iron, available in formulations like Floradix Liquid Iron & Vitamin Formula from £46.59, plays a crucial role in mitochondrial function and energy metabolism. A balanced approach to nutritional supplementation, guided by clinical assessment, often proves more effective than single-nutrient interventions.

Making an Informed Decision About NAD+ Therapy

If you're considering nad+ injections, it's essential to weigh the limited clinical evidence against potential costs and risks. Speak with a qualified healthcare professional who can assess your individual health status, review your current medications, and discuss whether NAD+ therapy—or more established alternatives—aligns with your health goals.

At Cured Pharmacy, our UK-registered clinical team is available to provide evidence-based guidance on supplementation strategies that support energy, metabolism, and overall wellbeing. We stock a comprehensive range of licensed vitamins and supplements, all dispensed with professional oversight and transparent pricing.

Rather than pursuing experimental therapies with uncertain benefits, many patients achieve meaningful improvements through optimised nutrition, regular physical activity, and management of underlying health conditions. Our pharmacists can help you develop a personalised approach based on current clinical guidelines and your individual circumstances.

Scientific References

1. Covarrubias, A. J., Perrone, R., Grozio, A., & Verdin, E. (2021). NAD+ metabolism and its roles in cellular processes during ageing. Nature Reviews Molecular Cell Biology, 22(2), 119–141. https://doi.org/10.1038/s41580-020-00313-x
2. Shade, C. (2020). The Science Behind NMN–A Stable, Reliable NAD+ Activator and Anti-Aging Molecule. Integrative Medicine: A Clinician's Journal, 19(1), 12–14.
3. Katsyuba, E., Romani, M., Hofer, D., & Auwerx, J. (2020). NAD+ homeostasis in health and disease. Nature Metabolism, 2(1), 9–31. https://doi.org/10.1038/s42255-019-0161-5
4. Grant, R., Berg, J., Mestayer, R., Braidy, N., Bennett, J., Broom, S., & Watson, J. (2019). A pilot study investigating changes in the human plasma and urine NAD+ metabolome during a 6 hour intravenous infusion of NAD+. Frontiers in Aging Neuroscience, 11, 257. https://doi.org/10.3389/fnagi.2019.00257

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication or supplement regimen.